🇰🇷 dapagliflozin and saxagliptin in South Korea

dapagliflozin and saxagliptin (dapagliflozin and saxagliptin) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

dapagliflozin and saxagliptin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is dapagliflozin and saxagliptin approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for dapagliflozin and saxagliptin in South Korea?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.